Author

A. Mandoli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Mathur· 1 shared A. Sharma· 1 shared B. Kim· 1 shared E. Tijchon· 1 shared E. van den Akker· 1 shared G. A. Nzelu· 1 shared G. Cordonnier· 1 shared G. Yi· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Mathur

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Deciphering drug response and phenotypic heterogeneity of cancer cells using gene ensembles of regulatory units defined by chromatin domains

N. Pandey, M. Sharma, A. Mathur, G. A. Nzelu, M. Hakimullah, I. P. Jha, O. Chandra, S. Mishra, J. Bhattacharya, A. Sharma, R. Foo, K. S. Sandhu, A. Mandoli, R. DasGupta, V. KUMAR

The paper analyzes the relationship between TAD activity and drug response in cancer cells and patients, finding stronger correlations with TADs than individual genes.

bioRxiv · Jan 15, 2023 · PreprintCancer Biology

CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1

G. Yi, A. Mandoli, L. Jussen, E. Tijchon, G. Cordonnier, M. Hansen, B. Kim, L. N. Nguyen, P. Jansen, M. Vermeulen, E. van den Akker, J. Bond, J. H. A. Martens

This study shows that the CBFβ-MYH11 fusion protein inhibits megakaryocyte differentiation by disrupting the GATA2 and KLF1 gene program in inv(16) AML cells.

bioRxiv · Oct 29, 2018Cancer Biology